general
Discontinuation Patterns With Omalizumab
Distinct comorbidities among patients with chronic urticaria led to different discontinuation patterns with omalizumab.
Study authors explained that while omalizumab is the recommended second-line therapy for chronic urticaria, there is a lack of clinical evidence “regarding long-term drug survival and determinants of discontinuation.”
This systematic review and meta-... [1533 chars]
Read Full ArticleShare this story
Up next
Related Stories
Assam bypoll: Nagaon Lok Sabha constituency profile, candidates, key facts
thehindu.com
New video shows chaos on flydubai flight after Indian pilot foils attack
The Indian Express
While restoring case, Madhya Pradesh High Court asks lawyer for community service
The Indian Express
In age of WhatsApp messages, why LPU other university need security rethink
The Indian Express
यूएस: हूती विद्रोहियों को मदद पहुंचाने के आरोप में अमेरिकी इंजीनियर गिरफ्तार, एफबीआई ने कैसे कसा शिकंजा?
Amar Ujala